Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 8, 1999, Pages 2038-2042

  Korting, Hans C ^a   Schaller, Martin ^a   Eder, Gabriele ^a   Hamm, Gerald ^a   Böhmer, Ursula ^a   Hube, Bernhard ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; INDINAVIR; PEPSTATIN; PROTEINASE INHIBITOR; SAQUINAVIR;

ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHENOTYPE; PRIORITY JOURNAL; THRUSH; VIRULENCE;

EID: 0032873005     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.8.2038     Document Type: Article

References (39)

1. Abad-Zapatero, C., R. Goldman, S. W. Muchmore, C. Hutchins, K. Stewart, J. Navaza, C. D. Payne, and T. L. Ray. 1996. Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implication for the design of antifungal agents. Protein Sci. 5:640-652.
2. Borg-von Zepelin, M., S. Beggah, K. Boggian, D. Sanglard, and M. Monod. 1998. The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages. Mol. Microbiol. 28:543-554.
3. Borg-von Zepelin, M., and R. Rüchel. 1988. Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect. Immun. 56:626-631.
4. Caniaux, I., J. Villard, and J. P. Gayral. 1985. Détection automatisée de l'assimilation des sources de carbone par les levures: etude préliminaire. Bull. Soc. Franc. Mycol. Med. 14:269-276.
5. Colina, A. R., F. Aumont, M. Deslauriers, P. Belhumeur, and L. De Repenigny. 1996. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect. Immun. 64:4514-4519.
6. De Bernardis, F., M. Boccanera, D. Adriani, E. Spreghini, D. Santoni, and A. Cassone. 1997. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun. 65:3399-3405.
7. De Bernardis, F., M. Boccanera, L. Rainaldi, C. E. Guerra, I. Quinti, and A. Cassone. 1992. The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects. Eur. J. Epidemiol. 8:362-367.
8. De Bernardis, F., A. Cassone, J. Sturvetant, and R. Calderone. 1995. Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis. Infect. Immun. 63:1887-1892.
9. Deeks, S. G., M. Schmith, M. Holodniy, and J. O. Kahn. 1997. HIV-1 protease inhibitors. A review for clinicians. JAMA 277:145-153.
10. Fallon, K., K. Bausch, J. Noonan, E. Huguenel, and P. Tamburini. 1997. Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect. Immun. 65:551-556.
11. Ghannoum, M., and K. Abu Elteen. 1986. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. J. Med. Vet. Mycol. 24:407-413.
12. Hoegl, L., E. Thoma-Greber, M. Röcken, and H. C. Korting. 1998. Shift from persistent oral pseudomembranous to erythematous candidosis in a human immunodeficiency virus (HIV)-infected patient upon combination treatment with an HIV protease inhibitor. Mycoses 41:213-217.
13. Hoegl, L., E. Thoma-Greber, M. Röcken, and H. C. Korting. 1998. HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: results of a study over a period of 2 years. Mycoses 41: 321-325.
14. Hoegl, L., M. W. Ollert, and H. C. Korting. 1996. The role of Candida albicans secreted aspartic proteinase in the development of candidoses. J. Mol. Med. 74:135-142.
15. Hoetelmans, R. M., P. L. Meenhorst, J. W. Mulder, D. M. Burger, C. H. Koks, and J. H. Beijnen. 1997. Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir. Pharm. World Sci. 19:159-175.
16. Homma, M., T. Kanabe, C. Hiroji, and K. Tanak. 1991. Detection of intracellular forms of secretory aspartic proteinase in Candida albicans. J. Gen. Microbiol. 138:627-633.
17. Hube, B. 1996. Candida albicans secreted aspartyl proteinases. Curr. Top. Med. Mycol. 7:55-69.
18. Hube, B., M. Monod, D. A. Schofield, A. J. P. Brown, and N. A. R. Gow. 1994. Expression of seven members of the gene family encoding secretory aspartyl proteinase in Candida albicans. Mol. Microbiol. 14:87-99.
19. Hube, B., D. Sanglard, M. Monod, D. A. Schofield, A. J. P. Brown, and N. A. R. Gow. 1997. Extracellular proteolytic activity of Candida species, p. 109-122. In H. Vanden Bossche, D. A. Stevens, and F. C. Odds (ed.), Host-fungus interplay. Proceedings of the Fifth Symposium on Topics in Mycology 1995. National Foundation for Infectious Diseases, Bethesda, Md.
20. Hube, B., D. Sanglard, F. C. Odds, D. Hess, M. Monod, W. Schäfer, A. J. P. Brown, and N. A. R. Gow. 1997. Gene disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 in Candida albicans attenuates virulence. Infect. Immun. 65:3529-3538.
21. Kato, I., T. Yasunuga, Y. Ikawa, and Y. Yoshinaka. 1987. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor. Nature 329: 654-656.
22. Kwon-Chung, K. J., D. Lehman, C. Good, and P. T. Magee. 1985. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect. Immun. 49:571-575.
23. MacDonald, F., and F. C. Odds. 1983. Virulence for mice of a proteinase-secreting stain of Candida albicans and a proteinase-deficient mutant. J. Gen. Microbiol. 129:431-438.
24. Monod, M., G. Togni, B. Hube, D. Hess, and D. Sanglard. 1998. Cloning, sequencing and expression of two new members of the secreted aspartyl proteinase family of Candida albicans. Microbiology 144:2731-2737.
25. Morschhäuser, J., R. Virkola, T. K. Korhonen, and J. Häcker. 1997. Degradation of human subendothelial extracellular matrix by proteinase-secreting Candida albicans. FEMS Microbiol. Lett. 153:349-355.
26. Moyle, G. 1994. Resistance to antiretroviral compounds. Mediscript, London, United Kingdom.
27. Odds, F. C. 1988. Candida and candidosis, 2nd ed. Ballière Tindall, London, United Kingdom.
28. Ollert, M. W., R. Söhnchen, H. C. Korting, U. Ollert, S. Bräutigam, and W. Bräutigam. 1993. Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect. Immun. 61:4560-4568.
29. Ollert, M. W., C. Wende, M. Görlich, C. G. McMullan-Vogel, M. Borg-von Zepelin, C.-W. Vogel, and H. C. Korting. 1995. Increased expression of Candida albicans secretory proteinase, a virulence factor, in isolates from human immunodeficiency virus-positive patients. J. Clin. Microbiol. 33: 2543-2549.
30. Perry, C. M., and S. Noble. 1998. Saquinavir soft-gel capsule formulation. Drugs 55:461-486.
31. Ray, T. L., and C. D. Payne. 1988. Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase. Infect. Immun. 56:1942-1949.
32. Rüchel, R. 1981. Properties of a purified proteinase from the yeast Candida albicans. Biochim. Biophys. Acta 659:99-113.
33. Rüchel, R., B. Ritter, and M. Schaffrinski. 1990. Modulation of experimental systemic murine candidosis by intravenous pepstatin A. Zentbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig. 273:391-403.
34. Sanglard, D., B. Hube, M. Monod, F. C. Odds, and N. A. R. Gow. 1997. A triple deletion in SAP4, SAP5, and SAP6 secretory aspartyl proteinase genes of Candida albicans causes attenuated virulence. Infect. Immun. 65:3539-3546.
35. Schaller, M., W. Schäfer, H. C. Korting, and B. Hube. 1998. Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol. Microbiol. 29: 605-616.
36. Schaller, M., W. Schäfer, H. C. Korting, and B. Hube. Unpublished data.
37. Watts, H. J., F. S. H. Cheah, B. Hube, D. Sanglard, and N. A. R. Gow. 1998. Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinases genes. FEMS Microbiol. Lett. 159:129-135.
38. White, T. C., and N. Agabian. 1995. Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, levels are determined by environmental factors. J. Bacteriol. 177:5215-5221.
39. Zingman, B. S. 1996. Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir. N. Engl. J. Med. 334: 1674-1675.